Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched With Essential Oils From Laboratoires Gilbert in Patient With Acute Rhinitis Associated With Nasal Obstruction

Inclusion Criteria: * 1\. Patient ≥ 12 years, * 2\. Patient with acute rhinitis associated with nasal obstruction during infectious episodes such as rhynopharyngitis (cold), rhinosinusitis, or during non-infectious episodes as allergic rhinitis, * 3\. a. Informed adult patient who has given written consent prior to any study specific procedure, * b. Informed minor patients who has given assent and whose legal guardians have given written consent prior to any study specific procedure, * 4\. Patient able to meet the study requirements (questionnaire completion), * 5\. Patient affiliated to a social security scheme. Exclusion Criteria: * 1\. Patient who does not want to participate to the clinical investigation, * 2\. Hypersensitivity to seawater and/or known allergies to any of the ingredients of the spray, * 3\. A child with a history of febrile convulsions, * 4\. Diseases leading to respiratory insufficiency, * 5\. Patient suffering from nasal deformity or nasal polyps leading to chronic nasal obstruction, * 6\. Patient on local ans systemic vasoconstrictors, local and systemic corticosteroids and antihistamines, non-steroidal anti-inflammatory (NSAIDs), antibiotics and local antiseptics, * 7\. Concomitant use of other nasal sprays, essential oils for local nasal use and nsal cream or gel, * 8\. Patient under guardianship, curatorship of safeguard of justice.